X4 Pharmaceuticals, Inc. (XFOR) - Latest Market Data

Price & Market Data

Price: $4.04

Daily Change: $0.00 / 0.00%

Daily Range: $4.00 - $4.20

Market Cap: $381,051,584

Daily Volume: 177,812

Performance Metrics

1 Week: 3.90%

1 Month: -1.79%

3 Months: 35.25%

6 Months: 10.59%

1 Year: 51.65%

YTD: 1.10%

About X4 Pharmaceuticals, Inc. (XFOR)

Explore comprehensive market data for X4 Pharmaceuticals, Inc. (XFOR). Currently priced at 4.04, observe its daily movement of $0.00 / 0.00%. The total market value is 381,051,584. Review its performance across various timeframes, including the last week, month, and year, to understand its trajectory.

Company Details

Employees: 45

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.

Selected stocks

111, Inc. (YI)

Elutia, Inc. (ELUT)

Cellectis S.A. (CLLS)

Highway Holdings Limited (HIHO)

New Found Gold Corp (NFGC)